U-Blot® Research Grade SirukumabCat. No. WA3544Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SirukumabCat. No. WA3544
U-Blot® Research Grade SirtratumabCat. No. WA3543
U-Blot® Research Grade SirexatamabCat. No. WA3542
U-Blot® Research Grade SiplizumabCat. No. WA3541
U-Blot® Research Grade SipavibartCat. No. WA3540
U-Blot® Research Grade SintilimabCat. No. WA3539
U-Blot® Research Grade SimtuzumabCat. No. WA3538
U-Blot® Research Grade SimridarlimabCat. No. WA3537
U-Blot® Research Grade Simlukafusp alfaCat. No. WA3536
U-Blot® Research Grade SimaravibartCat. No. WA3535
U-Blot® Research Grade SiltuximabCat. No. WA3534
U-Blot® Research Grade SiltartoxatugCat. No. WA3533